Currently, sustainability has become a fundamental axis for the pharmaceutical industry. In this context, Klinea stands out for its strong commitment to responsible and sustainable practices. We talked to Joan Cano, head of the Utilities & Process Department.
“From a pharmaceutical engineering perspective, the challenge ahead of us is to contribute the maximum knowledge in the projects we design, so that we can reduce the CO₂ footprint and contribute to the sustainability of the planet,” says Joan.
These challenges are part of our team’s daily work, since at Klinea we integrate the most innovative technologies and the most advanced sustainability criteria in a transversal manner. Thus reinforcing our strategic commitment to a more responsible and efficient future.
Klinea and BCorp: a unique opportunity for leadership in pharmaceutical engineering
It is worth mentioning the role of BCorp, a certification that identifies those companies with the highest standards in sustainability. BCorp promotes networking, collaboration and the exchange of solutions to face common challenges. However, there is currently no engineering company in the pharmaceutical sector within this group. “This fact represents a strategic opportunity for Klinea to position itself as a benchmark in sustainability within this highly specialized field”, says the Utilities & Process manager.
Responsibilities at Klinea and at ISPE Iberia
In addition to his work at Klinea, Joan Cano also leads the sustainable practices committee of the International Society for Pharmaceutical Engineering (ISPE) Iberia, from where he outlines a clear vision of the challenges that will mark the future of the sector.
Having the head of ISPE’s sustainability working group within Klinea brings a double advantage: it strongly positions the company and makes the knowledge on sustainability constantly updated. This positioning allows Klinea to be at the forefront of best practices in the sector and to share valuable experiences that enrich its projects.
Thanks to the experience accumulated at ISPE, knowledge transfer among industry experts is of great value, allowing Klinea’s projects to incorporate innovations and advanced sustainability criteria. “Collaboration with other leaders in the field is a constant source of added value, driving the design and execution of more responsible projects,” comments the Utilities & Process manager.
Sustainability measures and objectives at Klinea
Among the key objectives for the coming years, Cano highlights the implementation of a strategic sustainability plan, the publication of the first sustainability report in 2025 and the launch of an internal tool for calculating environmental impact.
In addition, Klinea incorporates ESG (environmental, social and governance) criteria in the supplier approval process, thus reinforcing the sustainable management of the value chain.
It is clear to us that the future of pharmaceutical engineering must be built on a firm commitment to the values of sustainability. Because the future cannot wait, it starts today and needs us to be more committed than ever.
At Klinea we develop engineering solutions for both the pharmaceutical and biotechnology sectors, integrating sustainability and technology from project conception.
